Key levels and trade conditions
Delayed quotes · Technical conditionsShowing the near-term range, based on the latest 5 completed sessions and updated after each close.
Hold and monitor; no addition yet
Signals require closing-price and volume confirmation; review the company research below before acting.
When does defense take priority?
Close beyond this level with session volume ≥ 1.5× the previous 20 completed sessions’ average.
Confirmed close below $31.72 → consider reducing
When to consider adding?
Close beyond this level with session volume ≥ 1.5× the previous 20 completed sessions’ average.
Confirmed close above $39.53 → consider a staged addition
01Newstock overall assessment
The conclusion first, followed by the evidence that matters most.
Watch — await combined confirmation. An entry assessment has not yet been established.
02What happened recently
Company events, industry developments and market conditions — facts separated from possible explanations.
US 10Y yield 5.13%2026-11-13T16:23:04.000Z
VIX 20.652026-11-13T16:23:01.000Z
Dollar index 103.332026-11-13T16:28:11.000Z
Market and sector reference
AMKR -4.34% · SPY -0.92% · Peer average -4.46% (AMAT, ASML, CDNS, ENTG, KLAC, LRCX)
2026-11-13T16:38:25.000Z · Yahoo · Aligned-session reference, not a causal attribution.
Related news and impact paths
Recent news related to this stock
1 direct · 6 2nd-order · 0 thematicRanked by model assessment and recency. Labels use the original model impact, not expected returns. Impact percentages are model estimates, not observed price changes, probabilities or guaranteed returns.
- #1Impact2.6%FavorableDirectApple Squeezed These Chip Suppliers for Years. AI Is Helping Them Get Even.15d ago
When Apple-related advanced packaging and test demand rises, outsourced OSATs like Amkor typically benefit from higher content per unit.
Also named: ASML · AMAT · LRCX · TSM · NVDA · AAPL
- #2Impact1.4%Favorable2nd-orderNvidia Q3 FY2027 Preview: The Fabless Model Just Got A $279 Billion Footnote12d ago
The OSAT leader benefits from rising packaging complexity and a higher outsourcing ratio in AI-related assembly and test.
Also named: NVDA · AVGO · AMD · MU · TSM · ASX
- #3Impact0.9%Favorable2nd-orderMicron Stock Pops as Rival SK Hynix Fuels AI Frenzy With Two Bombshells16d ago
If HBM and advanced packaging demand keeps rising, test-and-packaging utilization and pricing power should improve.
Also named: MU · SKHY · SAMSUNG ELECTRONICS · 美光设备与材料供应链 · LRCX · AMAT
If high-end packaging demand keeps broadening out, OSAT players like Amkor can benefit indirectly, though more from the broader semiconductor cycle than from this single article.
Also named: NVDA · TSM · ASML · AMAT · UMC · SMCI
More complex high-speed packaging and system-level integration needs tend to lift demand for advanced packaging services.
Also named: COHR · LITE · FNSR · ANET · MRVL · VRT
If AMD-related test and advanced packaging demand strengthens, OSAT vendors get incremental order support.
Also named: AMD · NVDA · INTC · SMCI · DELL · HPE
- #7Impact0.7%Favorable2nd-orderAMD Stock Jumped After Its Report. I'd Wait for a Lower Price to Buy.9d ago
Greater packaging complexity at AMD typically supports outsourced assembly and test demand, though the effect depends on order allocation rather than one customer alone.
Also named: AMD · NVDA · AVGO · INTC · AMAT · LRCX
03Is the company worth considering?
Business quality, financials, valuation and analyst disagreements.
🏛️ Company factsSEC filings + FINRA official data
Annual revenue $6.7B · latest quarter up 0.2% YoY · reported FY net income of $374M · short-sale volume share below its recent available-day average.
FY revenue
$6.7B
2025-12
Latest Q YoY
+0.2%
Gross margin
14%
FY net income
$374M
Diluted EPS
$1.51
Short-sale volume share
43.3%
2026-11-05 · Recent available-day avg 50.7% · below recent average
Short-sale volume as a share of trades covered by the FINRA file, not all market trading or outstanding short positions. Changes do not establish that short sellers are adding or covering positions.
Historical results versus analyst expectations
🎯 Market expectations
Estimate context score Medium · 67/100Nasdaq analyst consensus · currently available data
- Sep 2026$0.76 vs $0.79-3.8%
- Jun 2026$0.70 vs $0.47+48.94%
- Mar 2026$0.33 vs $0.23+43.48%
- Dec 2025$0.69 vs $0.43+60.47%
The takeaway
EPS exceeded the corresponding consensus estimates by an average of 37.3% in the quarters shown. This is not a hurdle for the next report or a forecast of the stock's reaction. Analysts made 3 downward revisions over the past four weeks.
Analyst estimates, not our forecast · not investment advice
Analyst consensus and disagreement
Target-price summary $38.00–$85.00 · Consensus $62.43
Buy / hold / sell 4 / 4 / 0
Nasdaq · Retrieved 2026-11-13T16:39:47.588Z · The aggregate does not provide individual report dates or original theses. It does not establish undervaluation; no analyst rationale is inferred. Targets are not guaranteed outcomes.
Next-quarter EPS estimate (Dec 2026) $0.71 · $0.70–$0.73 · 4 analysts
Four-week estimate revisions: up / down 0 / 3
Estimate dispersion 4.2%
Nasdaq EPS forecasts · retrieved 2026-11-13T16:39:46.520Z04Is now a good time?
Trend, moving averages, volume and key price levels — not the decline alone.
Technical structure · Downtrend structure
MA5 $35.50
MA10 $35.77
MA20 $38.27
MA60 $46.12
Last completed-session close $37.12 (-2.57%) · Volume / prior 20-session average 0.43×
Prior 20-session range $30.36–$44.50 · MA20 change over five sessions -6.84% · CMF20 -0.15
- Distribution-like weak closes (inference)
Confirmation to watch: a close above $44.50 with volume at least 1.5× the prior 20-session average. A heavy-volume break below $30.36 weakens the setup.
Completed daily candles only. Daily OHLCV cannot establish accumulation, shakeout or manipulation intent; CMF is a price/volume proxy, not actual fund flows. Thresholds are research rules, not validated success probabilities. Yahoo · 2026-11-12
Price and news
Historical prices and volume. Drag to pan; scroll to zoom.
Related news
05What would change our assessment?
Conditions for reconsidering entry and developments that invalidate the thesis.
Complete the company and technical cross-check before defining entry and invalidation conditions.
Additional risk evidence and model detail
Market View
Crowding
Risk temperature
Tail risk
Triggers
Price and volume
Insider signals
See every affected stock, second-order impact and risk factor. Try Pro free for 7 days — no credit card required.
Start my free trial